Andrew Shearer Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

1/2018

Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Shearer Research Topics

Disease

2	Neoplasms (Cancer) 02/2023 - 10/2008
1	Pain (Aches) 02/2023
1	Lung Neoplasms (Lung Cancer) 02/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Atherosclerosis 01/2018
1	Acute Coronary Syndrome 01/2018
1	Neuromyelitis Optica (Devic's Disease) 05/2015
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2015
1	Multiple Sclerosis 06/2009

Drug/Important Bio-Agent (IBA)

2	Immunoglobulin G (IgG)IBA 05/2015 - 06/2009
1	bivalirudin (Angiomax)FDA Link 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Thrombin FDA Link 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Aquaporins (Water Channels)IBA 05/2015
1	Aquaporin 4IBA 05/2015
1	DystrophinIBA 01/2015
1	Oligoclonal BandsIBA 06/2009
1	AntibodiesIBA 06/2009
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 10/2008

Therapy/Procedure

1	Palliative Care (Palliative Therapy) 02/2023
1	Percutaneous Coronary Intervention 01/2018
1	Therapeutics 10/2008